Opaleye Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Hold |
|
|||||
|
2025
Q1 | $11.7M | Sell |
|
|||||
|
2024
Q4 | $37.1M | Sell |
|
|||||
|
2024
Q3 | $43.7M | Sell |
|
|||||
|
2024
Q2 | $36.3M | Sell |
|
|||||
|
2024
Q1 | $60.5M | Buy |
|
|||||
|
2023
Q4 | $27.1M | Sell |
|
|||||
|
2023
Q3 | $20.3M | Buy |
|
|||||
|
2023
Q2 | $29.8M | Sell |
|
|||||
|
2023
Q1 | $32.2M | Buy |
|
|||||
|
2022
Q4 | $17.1M | Sell |
|
|||||
|
2022
Q3 | $26.8M | Buy |
|
|||||
|
2022
Q2 | $24M | Hold |
|
|||||
|
2022
Q1 | $29.6M | Hold |
|
|||||
|
2021
Q4 | $41.6M | Sell |
|
|||||
|
2021
Q3 | $64.8M | Hold |
|
|||||
|
2021
Q2 | $91.9M | Hold |
|
|||||
|
2021
Q1 | $106M | Sell |
|
|||||
|
2020
Q4 | $135M | Buy |
|
|||||
|
2020
Q3 | $45.5M | Hold |
|
|||||
|
2020
Q2 | $49.8M | Buy |
|
|||||
|
2020
Q1 | $25.4M | Buy |
|
|||||
|
2019
Q4 | $20.2M | Buy |
|
|||||
|
2019
Q3 | $8.44M | Sell |
|
|||||
|
2019
Q2 | $13M | Buy |
|
|||||
|
2019
Q1 | $7.54M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $5.5M | Sell |
|
|||||
|
2018
Q2 | $7.5M | Hold |
|
|||||
|
2018
Q1 | $7.23M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $5.1M | Buy |
|
|||||
|
2016
Q4 | $783K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.29M | Buy |
|